PHARMACEUTICAL COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING OSTEOARTHRITIS, CONTAINING RHODANINE DERIVATIVE AS ACTIVE INGREDIENT
申请人:Avixgen Inc.
公开号:EP3827827A1
公开(公告)日:2021-06-02
The present disclosure relates to the use of a rhodanine derivative in the prevention, amelioration or treatment of osteoarthritis. The rhodanine derivative according to the present disclosure has excellent effects of rescuing the loss of the cartilage matrix and alleviating synovitis, and thus may be effectively used for the prevention, amelioration or treatment of osteoarthritis.
本公开涉及一种罗丹宁衍生物在预防、改善或治疗骨关节炎中的用途。根据本公开的罗丹宁衍生物在挽救软骨基质的损失和缓解滑膜炎方面具有极佳的效果,因此可有效地用于预防、改善或治疗骨关节炎。